Stryker is proud to offer one of the lightest resectoscopes on the market at only 188 grams! The sleek, ergonomic design incorporates a superior flow rate with effortless resection and intuitive lock
The PK Plasma-CISE™ (wire electrodes) and Plasma-CUT™ (coiled electrodes) are single use devices that produce precise, consistent tissue cutting with minimal thermal spread and Vapor seal
Medium Surgical Clips. 6 clips per cartridge. Box of 30 cartridges with a total of 180 titanium clips per box. For secure vasal and other occlusion.
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures.
Medicine Products:(Date:9/5/2008)...ates call on John McCain to commit to develop a Na...d ST. PAUL, Minn., Sep. 5 /PRNewswire-USNewswire/ ...st night with no mention of the,domestic AIDS epid...ce to,the epidemic overseas. Neither Presidential ...inee Gov. Sarah Palin mentioned AIDS in their rema...
(Date:9/5/2008)... PLAINS, N.Y., Sept. 5 /PRNewswire/ -- Tonight is ... networks, entertainment industry,executives, cele...nd,patient advocacy join forces to Stand Up to Can...lcast from 8:00 p.m. to 9:00 p.m. ET on the three,...ented platform to elevate,the discussion about can...
(Date:9/5/2008)...NGTON, Sept. 5 /PRNewswire-USNewswire/ -- As the g...the National Federation of Independent,Business ( ...ential,candidates for a greater focus on the healt...ocratic and Republican conventions are over, NFIB,...gnificant obstacles faced,by small businesses as t...
(Date:9/5/2008)...ton, DCWomen with hormone-receptor positive, metas... to help keep their cancer at bay, but when the tu...tment with chemotherapy becomes the only option. B... Cancer Symposiummay change this approach. Early ...sitize" the tumor, allowing anti-hormonal drugs to...
Breaking Medicine News(10 mins):Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3Health News:The Leukemia & Lymphoma Society: Standing Up to Cancer for 60 Years 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3Health News:1 step back ... 2 steps forward 2(Date:9/5/2008)...wswire-FirstCall/ -- CEL-SCI Corporation,(Amex: C...oid arthritis data,at the Marcus Evans conference ...d by Dr. Daniel Zimmerman, Senior Vice President o...te that CEL-SCI,s rheumatoid,arthritis vaccine CEL...age,caused by rheumatoid arthritis in an animal mo...
(Date:9/4/2008).... 4 /- Cytopia Limited (ASX:,CYT) tod...ts Phase Ib/II,study of CYT997, the company,s nove...s with an aggressive form of brain cancer known as... trial is the first Phase II efficacy study in hig...any and the second in its,suite of Phase II studie...
(Date:9/4/2008)... Lancet, and Presented at ESC Congress-, PHILADEL...nternational,study, the GISSI Heart Failure (GISSI... ethyl esters reduced all cause mortality and hosp...ents with chronic heart,failure. These findings ar...Lancet, and were presented at the European Cardiov...
(Date:9/4/2008)...mber 4 /- Axentis Pharma AG has,initi...ty and tolerability,of a new therapeutic formulati... in cystic fibrosis patients. The new formulation ...vered directly to the site of,infection. The forth...different doses of the new drug. Initial results a...
Breaking Medicine Technology:Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Microbes churn out hydrogen at record rate 1201 1Microbes churn out hydrogen at record rate 1201 2Thomson Healthcare Launches Application That Assesses Physician Performance 6196 1Thomson Healthcare Launches Application That Assesses Physician Performance 6196 2Thomson Healthcare Launches Application That Assesses Physician Performance 6196 3Phoenix Health Systems Project Management Office Service Line is Recognized by the Project Management Institute as a Registered Education Provider 6194 1Phoenix Health Systems Project Management Office Service Line is Recognized by the Project Management Institute as a Registered Education Provider 6194 2Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two Year Lease for Chrysler 300C 6192 1Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two Year Lease for Chrysler 300C 6192 2Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two Year Lease for Chrysler 300C 6192 3...Newswire-FirstCall/ - Pacgen,Biopharmaceuticals Co...line results from its Phase I/II study of PAC-113,...ll-tolerated, and active,in the treatment of oral ...ble to the current standard of care. Based on thes...b study to optimize PAC-113,dose and formulation. ...
...nto Later Stage Clinical,Trials, BALTIMORE, May 07...on today announced preliminary results from its Ph...h Celiac Disease (CD), an,autoimmune disease affec...lba,s study, the first Phase IIa trial in CD and t... in CD, was designed to,evaluate the safety, toler...
Other Medicine Technology:Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 2Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 3Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 4Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 5Alba Therapeutics Corporation Reports Preliminary Phase IIa,Clinical Trial Results for AT-1001 for the Treatment of Celiac,Disease 2Alba Therapeutics Corporation Reports Preliminary Phase IIa,Clinical Trial Results for AT-1001 for the Treatment of Celiac,Disease 3